Time in Range: How CGM Metrics Help You Manage Diabetes Daily

Most people with diabetes know their HbA1c number. It’s the three-month average that doctors use to judge how well your blood sugar is controlled. But what if that number is hiding dangerous spikes and drops you never see? That’s where time in range changes everything.

What Time in Range Really Means

Time in range (TIR) isn’t a fancy term-it’s simple: it’s the percentage of time your blood glucose stays between 70 and 180 mg/dL (3.9-10.0 mmol/L). That’s your sweet spot. If you’re using a continuous glucose monitor (CGM), your device tracks your glucose every 1 to 5 minutes, day and night. Over 14 days, that’s over 1,300 readings. TIR takes all those numbers and tells you how much time you spent in that healthy zone.

The goal? At least 70% of the day. That means 17 hours out of 24 where your sugar stays steady-not too high, not too low. This isn’t a guess. It’s backed by the 2019 International Consensus and the 2025 American Diabetes Association (ADA) Standards of Care. And it’s not just for people on insulin anymore. The ADA now says CGM and TIR should be considered for any adult with type 2 diabetes on glucose-lowering meds, even if they’re not injecting insulin.

Why TIR Beats HbA1c Alone

HbA1c gives you a blur. Imagine reading only the last page of a novel. You know how it ends, but you miss all the drama in between. That’s HbA1c. Two people can have the same HbA1c of 7.0%, but one spends 80% of the day in range while the other spends 40% of the day above 200 mg/dL and 10% below 70 mg/dL. One is stable. The other is in danger-facing more risk of nerve damage, eye problems, and dangerous lows.

TIR shows you the full story. It tells you when your sugar spikes after lunch. It shows you if your overnight lows happen every Tuesday. It reveals hidden patterns HbA1c never could. That’s why experts now call TIR a new gold standard-not to replace HbA1c, but to work with it. Think of HbA1c as your yearly report card. TIR is your daily progress log.

The Numbers Behind the Screen

CGM devices don’t just show you one number. They give you a full dashboard:

• Time in Range (TIR): 70-180 mg/dL (target: ≥70%)
• Time Below Range (TBR): Below 70 mg/dL (target: <4%)
• Time Above Range (TAR): Above 180 mg/dL (target: <25%)
• Severe Hypoglycemia: Below 54 mg/dL (target: <1%)
• Glucose Variability: How much your numbers swing up and down (lower is better)

Some people, especially those aiming for tighter control, look at a tighter range: 70-140 mg/dL. That’s closer to what someone without diabetes experiences. Early research suggests this might reduce long-term risks even further, but it’s still being studied. For now, 70-180 mg/dL is the standard for most adults.

How Real People Use TIR to Change Their Habits

One patient in Birmingham noticed her TIR dropped every Thursday. She couldn’t figure out why-she ate the same meals, exercised the same. Then she checked her CGM data. Every Thursday, she had a small glass of orange juice with breakfast. "It’s just juice," she said. But the graph showed her sugar jumped to 210 mg/dL within 20 minutes. She switched to water with lemon. Within two weeks, her TIR went from 58% to 76%.

Another man found his nighttime lows happened after walking his dog at 9 p.m. He’d always thought evening walks were healthy. But his CGM showed his sugar dropped 40 points after each walk. He started walking at 7 p.m. instead. No more nighttime lows.

TIR doesn’t just tell you your sugar is off. It tells you why. And that’s powerful. You start making decisions based on data, not guesswork. You learn which foods spike you, which workouts lower you, and when your stress hits hardest. It turns diabetes management from a chore into a puzzle you’re actually solving.

What You Need to Get Started

You can’t measure TIR without a CGM. The most common devices-Dexcom, Abbott’s Freestyle Libre, and Medtronic-stick to your arm or belly and send readings to your phone. Most wear for 10 to 14 days before needing replacement. The FDA has cleared these devices, and Medicare and Medicaid now cover them for many people with type 2 diabetes who meet certain criteria.

But here’s the catch: you need to wear it. At least 70% of the time. If you take it off for three days, your data isn’t reliable. And you need to learn how to read it. A single glance at a graph won’t help. You need to understand what the colors mean, how to spot trends, and when to call your care team.

Most clinics now offer 1-2 sessions with a diabetes educator to walk you through your first CGM report. They’ll show you how to spot patterns, adjust meals, and respond to alerts. Don’t skip this. It’s the difference between seeing data and using it.

Barriers and What’s Changing

Cost used to be the biggest roadblock. CGMs were expensive, and insurance often only covered them for insulin users. That’s shifting fast. The 2025 ADA guidelines changed everything. By recommending CGM for all adults with type 2 diabetes on glucose-lowering meds-even metformin or GLP-1s-the barrier is falling.

The global CGM market is growing fast. It was worth $4.8 billion in 2022 and could hit $18.6 billion by 2030. More people are using them. In the U.S., CGM use among Medicare beneficiaries with type 2 diabetes jumped from 15% in 2019 to 42% in 2023. More coverage, more data, more proof it works.

Still, some struggle with sensor discomfort, occasional calibration, or just the overwhelm of too much information. That’s normal. You don’t need to fix everything at once. Start by focusing on one thing: your morning spike. Or your after-dinner dip. Tackle one pattern. Then move to the next.

The Future Is Here

AI is starting to help. Some newer CGM apps now suggest small changes: "Try eating protein before carbs," or "Your sugar drops after evening walks-move your walk to earlier." These aren’t magic. They’re patterns you’ve already created, just analyzed faster.

Long-term studies are now linking higher TIR to lower risks of kidney disease, vision loss, and nerve damage. We’re not there yet with absolute proof for every complication, but the trend is clear: the more time you spend in range, the healthier you’ll be.

TIR isn’t just another metric. It’s a shift in how we think about diabetes. It moves us from waiting for a lab result to acting on real-time feedback. It gives you control-not just over your sugar, but over your life.

Time in range isn’t about perfection. It’s about progress. One extra hour in range today is one less spike tomorrow. And that’s how diabetes care is changing-for the better.